Drug Type Biological products |
Synonyms DWP 216262, DWP216262 |
Target |
Action inhibitors |
Mechanism TEAD1 inhibitors(TEA domain transcription factor 1 inhibitors), TEAD2 inhibitors(TEA domain transcription factor 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Mesothelioma | Preclinical | South Korea | 01 Jun 2025 | |
| Non-Small Cell Lung Cancer | Preclinical | South Korea | 01 Jun 2025 |





